These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3291557)
21. [Comparison of the anti-arrhythmic effects of propafenone and aprindine in the treatment of refractory chronic ventricular arrhythmias. A randomized double-blind crossover study controlled with placebo]. Purcaro A; Amici R; Ciampani N; Costantini C; Mocchegiani R; Pigini G G Ital Cardiol; 1983; 13(6):444-50. PubMed ID: 6357929 [TBL] [Abstract][Full Text] [Related]
22. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia]. Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study. Härtel G Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347 [TBL] [Abstract][Full Text] [Related]
24. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia]. Palmieri M; Capucci A; Lombardi G; Naccarella F; Bomba E; Bracchetti D G Ital Cardiol; 1984 May; 14(5):357-9. PubMed ID: 6468817 [TBL] [Abstract][Full Text] [Related]
25. Short- and long-term effects of propafenone in ventricular arrhythmias. Gaita F; Richiardi E; Bocchiardo M; Asteggiano R; Pinnavaia A; Di Leo M; Rosettani E; Brusca A Int J Cardiol; 1986 Nov; 13(2):163-70. PubMed ID: 3793276 [TBL] [Abstract][Full Text] [Related]
26. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity. Hodges M; Salerno D; Granrud G Am J Cardiol; 1984 Nov; 54(9):45D-50D. PubMed ID: 6388303 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of and adverse effects of disopyramide. Comparison of capsules, controlled release tablets and placebo in patients with chronic ventricular arrhythmias. Ekelund LG; Nilsson E; Walldius G Eur J Clin Pharmacol; 1986; 29(6):673-7. PubMed ID: 3519236 [TBL] [Abstract][Full Text] [Related]
28. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias. Kim SG; Mercando AD; Tam S; Fisher JD J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173 [TBL] [Abstract][Full Text] [Related]
29. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias. Breithardt G; Seipel L; Lersmacher J; Abendroth RR J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812 [No Abstract] [Full Text] [Related]
30. Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias. Nielsen H; Sørum C; Rasmussen V; Madsen JK; Hansen JF Acta Cardiol; 1990; 45(5):359-63. PubMed ID: 1704168 [TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study. Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506 [TBL] [Abstract][Full Text] [Related]
32. [Propafenone and flecainide in the therapy of ventricular arrhythmias]. Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814 [TBL] [Abstract][Full Text] [Related]
33. Intravenous disopyramide: safety and efficacy of a new dosage regimen. Reddy CP; Benes J; Beck B Clin Pharmacol Ther; 1984 May; 35(5):610-6. PubMed ID: 6713772 [TBL] [Abstract][Full Text] [Related]
34. Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias. Facchini M; Bonazzi O; Priori SG; Varisco T; Zuanetti G; Schwartz PJ Eur Heart J; 1988 May; 9(5):462-70. PubMed ID: 3402461 [TBL] [Abstract][Full Text] [Related]
35. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage. Carrasco HA; Vicuña AV; Molina C; Landaeta A; Reynosa J; Vicuña N; Fuenmayor A; López F Int J Cardiol; 1985 Dec; 9(4):425-38. PubMed ID: 3908329 [TBL] [Abstract][Full Text] [Related]
36. Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design. Pratt CM; Young JB; Francis MJ; Taylor AA; Norton HJ; English L; Mann DE; Kopelen H; Quinones MA; Roberts R Circulation; 1984 Feb; 69(2):288-97. PubMed ID: 6360413 [TBL] [Abstract][Full Text] [Related]
37. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases]. Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161 [TBL] [Abstract][Full Text] [Related]
38. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741 [TBL] [Abstract][Full Text] [Related]
39. Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction. Rehnqvist N; Ericsson CG; Eriksson S; Olsson G; Svensson G Acta Med Scand; 1984; 216(5):525-30. PubMed ID: 6395642 [TBL] [Abstract][Full Text] [Related]
40. [Effects of propafenone on arrhythmias induced by exertion in patients with ischemic cardiopathy]. Patané S; Virga T; Giannetto M; Luzza F; Oreto G; Arrigo F G Ital Cardiol; 1987 Jul; 17(7):605-8. PubMed ID: 3678712 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]